Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study.

Saved in:
Bibliographic Details
Title: Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study.
Authors: Palmeri, S.1 s_palmeri@libero.it, Vaglica, M.1, Spada, S.2, Filippelli, G.3, Farris, A.4, Massidda, B.5, Misino, A.6, Ferraù, F.7, Comella, G.8, Leonardi, V.9, Condemi, G.10, Mangiameli, A.11, De Cataldis, G.12, Macaluso, M. C.1, Cajozzo, M.13, Iannitto, E.1, Palmeri, L.1, Danova, M.14
Source: Oncology. 2005, Vol. 68 Issue 4-6, p438-445. 8p. 5 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:00302414
DOI:10.1159/000086986